Plasmonic modulation of the upconversion fluorescence in NaYF4 :Yb/Tm hexaplate nanocrystals using gold nanoparticles or nanoshells. (1/30)

 (+info)

A molecularly targeted theranostic probe for ovarian cancer. (2/30)

 (+info)

Fluorescent metal nanoshell probe to detect single miRNA in lung cancer cell. (3/30)

 (+info)

Recent progress in nanotechnology for cancer therapy. (4/30)

The application of nanotechnology significantly benefits clinical practice in cancer diagnosis, treatment, and management. Especially, nanotechnology offers a promise for the targeted delivery of drugs, genes, and proteins to tumor tissues and therefore alleviating the toxicity of anticancer agents in healthy tissues. This article reviews current nanotechnology platforms for anticancer drug delivery, including polymeric nanoparticles, liposomes, dendrimers, nanoshells, carbon nanotubes, superparamagnetic nanoparticles, and nucleic acid-based nanoparticles [DNA, RNA interference (RNAi), and antisense oligonucleotide (ASO)] as well as nanotechnologies for combination therapeutic strategies, for example, nanotechnologies combined with multidrug-resistance modulator, ultrasound, hyperthermia, or photodynamic therapy. This review raises awareness of the advantages and challenges for the application of these therapeutic nanotechnologies, in light of some recent advances in nanotechnologic drug delivery and cancer therapy.  (+info)

Visualizing light-triggered release of molecules inside living cells. (5/30)

 (+info)

Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy. (6/30)

 (+info)

Nanoshell-mediated photothermal therapy improves survival in a murine glioma model. (7/30)

 (+info)

Theranostics with multifunctional magnetic gold nanoshells: photothermal therapy and t2* magnetic resonance imaging. (8/30)

 (+info)